Chain Pharmacy

Fluticasone furoate and vilanterol inhalation powder combo is a long-term, once-daily maintenance treatment for COPD

Coming on the heels of FDA's denial of generic forms of OxyContin, the ruling triggers speculation about overall FDA strategy

Migraine prevention drugs used during pregnancy can cause decreased IQ scores in children born to mothers who take these medications, according to an FDA alert.

Leaders of the National Community Pharmacists Association (NCPA) and hundreds of its members were in Washington, DC, last week for a two-day advocacy-focused conference. They hope to garner support from Congress for leveling the playing field between pharmacy benefit managers (PBM) and independent community pharmacies.

The New Jersey Board of Pharmacy and the state’s Division of Consumer Affairs published a new pharmacy security guide to help prevent drug theft and diversion at retail pharmacies.

National Prescription Drug Take-Back nets 371 tons of Rx meds

The National Association of Chain Drug Stores (NACDS) has joined forces with other healthcare industry leaders to raise awareness of the need for better medication adherence and to advance public policy with near-term solutions.

Last month's judicial ruling that all women of any age have non-Rx access to the drug remains an issue

Legislation would create a new class of drug makers and strengthen FDA oversight

Clinical trials find tolvaptan may cause injury leading to liver transplant or death

Discoloration of skin and retina color have been reported

Prenatal exposure to valproate significantly increased the risk of autism spectrum disorder and childhood autism in the offspring of mothers who took the anti-epileptic agent, according to a study published in the April 24 issue of the Journal of the American Medical Association.

Pneumococcal conjugate vaccines have been introduced in 40% of WHO member states

Interim analysis found results ineffective

Actavis will be able to sell defined quantities of a generic version or an authorized generic version of reformulated OxyContin as early as next year, according to Purdue Pharma L.P., the manufacturer of the opioid analgesic.

Patients who fail to fill a new prescription for statin therapy have a number of reasons, including negative perceptions about the medication, a preference for lifestyle modifications, concerns about side effects, drug interactions, polypharmacy, and a perception that they do not need the drug, according to a study published by The American Journal of Managed Care.

FDA has approved a supplemental new drug application (sNDA) for lubiprostone (Amitiza, Sucampo Pharmaceuticals and Takeda Pharmaceuticals) 24 ?g twice daily as the first oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, noncancer pain.

To reach their full potential in healthcare delivery, community pharmacists must continue to participate, innovate, and communicate through the National Association of Chain Drug Stores (NACDS) for continued advancement, according to Gregory D. Wasson, chairman of the board of NACDS.

Generic OxyContin is off the table, and the branded drug gets a label warning that abuse of the product will be difficult

Repercussions of PBM consolidation

The new organization begins by defining its terms

Regardless of its status as an herbal dietary supplement, St. John's Wort is a drug

Alogliptin approved as monotherapy and in two combinations

Remember that Norman Rockwell image of the friendly local pharmacist, running his shop his way? Now blink. Hey! It's still there

Memories of the phenobarb generation